BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 

Sunday, 15 April, 2001, 23:01 GMT 00:01 UK
The Pill 'reduces bowel cancer risk'
Contraceptive pill
The contraceptive pill may have a double benefit
Women using the oral contraceptive pill could be up to 20% less likely to develop bowel cancer, research suggests.

Researchers believe that over the last 20 years, mortality rates for bowel cancer have dropped more in women than in men because of hormones found in the Pill.

They focused on the results from 19 international studies that compared bowel cancer rates for women who had taken an oral contraceptive between the mid-1960s and 1980s.


It might be possible for scientists to harness the anti-cancer properties of the Pill to help combat the UK's second biggest killer cancer

Professor Gordon McVie, Cancer Research Campaign
Lead researcher Dr Carlo La Vecchia, from the Institute of Pharmacological Research in Milan, Italy, said: "For a while now we have suspected oestrogen in the Pill could protect against bowel cancer and our research has gone some way to confirm this.

"Mortality rates for female bowel cancer have steadily dropped over the last 20 years - we believe this is partly due to the Pill.

"In the future, it may be possible to develop new treatments that take advantage of the anti-cancer qualities of the Pill."

Oestrogen the key

Researchers believe the protective benefits of the Pill are due to the way oestrogen - a female sex hormone - works in the body.

When oestrogen in the Pill is released into the body, it blocks the growth of cancer cells by reducing the amount of bile acids, which have been linked to colon cancer.

The oestrogen may also help to reduce levels of a hormone called IGF-I that has also been linked to an increased risk of bowel cancer.

IGF-1 is found in the blood and instructs cells to divide. But when the body produces too much of this hormone, these cells divide too quickly and can contribute to cancer development.

The results also indicated that protection was stronger for women who had stopped using oral contraceptives within the last 10 years of the research period, compared to those who had stopped taking the Pill for longer.

The Cancer Research Campaign's Director General, Prof Gordon McVie, said: "The results show that women might have a secret weapon against the disease that kills 46 people in the UK each day.

"In future, it might be possible for scientists to harness the anti-cancer properties of the Pill to help combat the UK's second biggest killer cancer."

Up to 34,000 people were diagnosed with bowel cancer in the UK in 1996 (17,0380 men and 16,690 women).

The disease killed up to 17,000 people in the UK in 1999.

The research is published in the British Journal of Cancer.

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE
See also:

19 Mar 01 | Health
Bowel cancer 'undetected'
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories